-
EP4381051
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4381051
| EP4381051 - NEURAL PROGENITOR CELLS AND THERAPEUTIC USES OF SAME [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 10.05.2024 Database last updated on 16.11.2024 | |
| Former | The international publication has been made Status updated on 10.02.2023 | Most recent event Tooltip | 11.10.2024 | Change: Validation states | published on 13.11.2024 [2024/46] | 11.10.2024 | Change - extension states | published on 13.11.2024 [2024/46] | Applicant(s) | For all designated states University Health Network 190 Elizabeth Street R. Fraser Elliott Building - Room 1S-417 Toronto, Ontario M5G 2C4 / CA | [2024/24] | Inventor(s) | 01 /
FEHLINGS, Michael George Toronto, Ontario M6S 2W5 / CA | 02 /
KHAZAEI, Mohammad Toronto, Ontario M6K 3N9 / CA | 03 /
AHUJA, Christopher S. Ajax, Ontario L1T 3J3 / CA | [2024/24] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [2024/24] | Application number, filing date | 22851513.6 | 03.08.2022 | [2024/24] | WO2022CA51178 | Priority number, date | US202163229140P | 04.08.2021 Original published format: US 202163229140 P | [2024/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023010209 | Date: | 09.02.2023 | Language: | EN | [2023/06] | Type: | A1 Application with search report | No.: | EP4381051 | Date: | 12.06.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.02.2023 takes the place of the publication of the European patent application. | [2024/24] | Search report(s) | International search report - published on: | CA | 09.02.2023 | Classification | IPC: | C12N5/0797, A61K35/30, A61P25/00, A61P25/28, C12N5/10, C12N15/10, C12N15/12, C12N15/63 | [2024/24] | CPC: |
A61P25/00 (EP,US);
A61K35/30 (EP,US);
A61P25/28 (EP);
C07K14/4702 (EP);
C12N5/0619 (EP);
C12N5/0623 (US);
C12N2501/115 (EP);
C12N2501/119 (EP,US);
C12N2501/13 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/24] | Title | German: | NEURALE VORLÄUFERZELLEN UND THERAPEUTISCHE VERWENDUNGEN DAVON | [2024/24] | English: | NEURAL PROGENITOR CELLS AND THERAPEUTIC USES OF SAME | [2024/24] | French: | CELLULES PROGÉNITRICES NEURALES ET LEURS UTILISATIONS THÉRAPEUTIQUES | [2024/24] | Entry into regional phase | 06.02.2024 | National basic fee paid | 06.02.2024 | Search fee paid | 06.02.2024 | Designation fee(s) paid | 06.02.2024 | Examination fee paid | Examination procedure | 06.02.2024 | Examination requested [2024/24] | 11.09.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.08.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [PY]WO2022051847 (UNIV HEALTH NETWORK [CA]); |